Every year, hundreds of thousands of pages are devoted to diagnostic problems in medicine. In books and medical journals, physicians constantly share their experiences, advance criteria for diagnosis, and alert to diagnostic pitfalls. One tremendous pitfall, however, probably the greatest of them all, is hardly ever mentioned, namely, specimen mix-up.
In addition to the dark figure whose true size, naturally, is shrouded in the dark, other factors hamper a systematic analysis of mistakes in the assignment of specimens. Among them are different criteria employed in studies dealing with mistakes in laboratory medicine, some studies including only cases of specimen mix-up that were not recognized and corrected immediately, others many other types of mistakes, ranging from loss of specimens to incomplete labeling of them that could be amended easily [3, 4] . Even inappropriate biopsies and incorrect interpretation of reports by clinicians have been dubbed "laboratory errors," in accordance with the definition of such errors as "any defect from ordering tests to reporting results and appropriately interpreting and reacting on these." [5] Moreover, data from one hospital or laboratory cannot be transferred readily to another, even if the same criteria are employed.
Methods of quality control
In tests of blood or urine, mix-up of specimens can be recognized in follow-up examinations if one result is not compatible with all the others. In order to facilitate recognition of such mistakes, Nosanchuk and Gottman in 1974 introduced the "delta check" that compares any two consecutive results for a given test on the same patient by subtracting the later result from the prior result and then dividing by the prior result. The delta value is determined for every new test and is compared to previous values. Each parameter has its own tolerance for deviation, and if the latter is exceeded, the respective case is submitted to further investigation [6, 7] . Because samples of blood or urine are generally used for analysis of several variables, the sensitivity of the method has been enhanced by introduction of a multivariate delta check 8, 9] . Another method advocated to detect laboratory errors is the "splitspecimen design," according to which samples from the same patient are analyzed by two different laboratories, and one part is stored away and analyzed only in the case of contradictory results [10] . In addition, co-determination of the blood group with every test, and comparison of it with the known blood group of the patient, has been advocated as a routine measure of quality control, although it does not help to detect mix-up of specimens of patients with the same blood group [11] . Given the rarity of specimen mix-up, the considerable costs and efforts associated with those methods of detection, and the limited sensitivity of them, the value of methods such as the delta check has been called in question [12] .
A mix-up of biopsy specimens is even more difficult to recognize than a mix-up of samples of blood or urine, the reason being that results, in general, cannot be compared to previous or subsequent data on the same parameter. Each biopsy specimen stands for itself. This is not only true for neoplasms excised completely but also for inflammatory dermatoses. Depending on the stage of development of a given lesion, the histopathologic findings in two biopsy specimens of the same disease in the same patient may differ strikingly, and a modification of the histopathologic presentation by unrelated factors, such as irritation, venous hypertension, or another co-existing disease, must always be expected.
Even within the same biopsy specimen, histopathologic findings may vary considerably, precluding the "split-specimen design" as a method of quality control. Moreover, splitting a specimen in several portions in order to have them examined by different laboratories, or to keep one portion in storage, would compromise severely the assessment of criteria for histopathologic diagnosis and, therefore, is not feasible for the vast majority of biopsy specimens in dermatopathology.
The suspicion of a specimen mix-up is raised especially by divergent diagnoses on the same neoplasm in an incisional biopsy and the subsequent re-excision specimen. However, two different neoplasms in the immediate vicinity of one another are not rare, especially in skin damaged severely by sunlight. Moreover, complete regression of a neoplasm following biopsy of it is a common phenomenon not only in basal-cell carcinoma, but also in squamous-cell carcinomas and melanocytic neoplasms [13] [14] [15] . Therefore, failure to find remnants of a biopsy-proven neoplasm, coupled with detection of a different neoplasm, does not necessarily imply a specimen mix-up. It does, however, raise the suspicion of it.
In order to prove or disprove that suspicion, studies can be performed to check the identity of the patient in both specimens. For that purpose, various methods have been proposed, ranging from immunohistochemical determination of the blood group or of the HLA class 1 antigen profile to molecular studies [16] [17] [18] . Immunohistochemical methods have advantages in complex cases. For example, in case of suspicion that some of many fragments of tissue in the same paraffin block come from a different patient, molecular analysis may be difficult, whereas differences in the immunohistochemical staining pattern of those fragments of tissue are detectable easily. However, identical blood groups are common, and even when studying the polymorphous HLA class 1 complex with a panel of five antibodies, identical results of different patients must be expected in 1% of cases [17] .
Molecular identity testing is far more sensitive. It is performed by short tandem repeat analysis, i.e., analysis of repeating sequences of 2-6 base pairs of DNA also known as "microsatellites." Because the latter show great variation in regard to the number of repeats and often many alleles at a microsatellite locus, they have been chosen for genetic fingerprinting in forensic medicine. With the use of commercially available kits for combined analysis of several loci, the probability of the same result in unrelated individuals is about 1 to 1 billion.
Since the late 1990s, short tandem repeat analysis has been employed increasingly for proving a mix-up of specimens in surgical pathology [18] [19] [20] [21] [22] .
A mix-up of specimens from the same patient, however, cannot be detected by any of those methods. Moreover, considering the rarity of specimen mix-ups, identity testing is far too laborious and costly to be performed as a routine measure. It is reserved for clarifying the suspicion of specimen mix-up, and the latter arises only if the result of an examination is not plausible. Sometimes, a mix-up of specimens is obvious. For example, if a biopsy specimen from the buttock of a newborn under the clinical diagnosis of a strawberry hemangioma shows a solar keratosis and large sebaceous glands in severely sun-damaged skin, clinical data and histopathologic findings are incompatible. If the next specimen comes in as a solar keratosis from the nose but shows a hemangioma, the issue is resolved. Usually, the question whether the mix-up occurred in the operating room or the laboratory cannot be decided, but all one needs to do for restoring order is to switch the numbers of both specimens.
In general, however, it is not that easy. For example, if there is also a vascular neoplasm in the first biopsy specimen, the histopathologist must be extremely alert in order to identify the specimen mix-up on the basis of anatomical differences or presence or absence of solar elastosis. If the first patient is not a newborn but an adult, this becomes more difficult. It is even more difficult if findings in only a single specimen do not fit, whereas histopathologic findings in preceding and subsequent specimens and in all specimens submitted by the same physician on the same day are compatible with the respective clinical data. There is no chance at all to discover a specimen mix-up if clinical diagnoses and anatomy are similar, e.g., a melanocytic nevus from the chest and a melanoma from the shoulder. In such instances, the mix-up either goes unnoticed or manifests itself months or years later by a local recurrence of the melanoma at the site of the alleged nevus.
The consequences may be dramatic, and they have been described in many case reports in the forensic medical literature. For example, in an elderly patient two biopsies were taken from the colon, one of which was reported as carcinoma and the other as normal bowel mucosa. Because the precise biopsy site had not been specified on the request slip, a subtotal colectomy was performed on the wrong segment of colon.
When histopathologic examination of it failed to reveal signs of malignancy, the mistake was clarified by another biopsy of the carcinoma that had been left untreated [23] . Biopsy of a gastric ulcer in a middle-aged woman revealed a carcinoma and resulted in gastrectomy. No residual malignancy was found in the surgical specimen. In an elderly man, a biopsy from the stomach was performed on the same day under the clinical diagnosis of carcinoma. It revealed only a mild gastritis that was treated conservatively. One year later, the patient died from metastasizing gastric cancer. A molecular analysis revealed that the biopsy specimens of both patients had been mixed-up [19] . A middle-aged woman underwent a breast biopsy that was diagnosed as infiltrating carcinoma. Based on this result, a total mastectomy and axillary lymph node dissection was performed. When histopathologic study of the specimens revealed no residual tumor, the original biopsy specimen was re-examined and failed to reveal carcinoma as well. The carcinoma was found in the preceding slide that the pathologist had taken inadvertently twice from tray, the second time giving the diagnosis of mammary carcinoma on the wrong patient [23] .
A nostrum to prevent such catastrophes does not exist.
Methods of quality control in laboratory medicine, such as the delta check and the "split-specimen design," cannot be applied. In order to prevent a mix-up of biopsy specimens, it has been proposed to ink all incoming specimens with six different colors in a defined sequence and to write down that color on the request form. In a study of 1000 breast core needle specimens, two mix-ups could be detected by a deviation of the color noted on the request form from the actual color of the specimen seen under the microscope. One of those mix-ups was caused by confusion of two paraffin blocks, the other by an incorrectly labeled specimen slide. In yet another case, a mix-up was faked by an incorrect declaration of the color on the request form; in that instance the additional measure caused confusion, rather than preventing it [24] . More importantly, the sensitivity of the method is low because a deviation of colors may be overlooked, a mix-up of specimens inked with the same color cannot be recognized, and a mix-up of specimens before or after procession of it in the laboratory cannot be detected. Most mix-ups, however, occur before procession of the specimen [3, 4] . Despite the high effort associated with it, that method does not provide great benefits.
Standardization
The best way to prevent and detect the mix-up of specimens seems to be good organization of all steps connected with a biopsy, from the surgical procedure itself to labeling of sample bottles and request forms in the operating room, accessioning of specimens in the laboratory, procession of specimens, assessment of histopathologic findings at the microscope, typing of dictations, transmission of reports, and, finally, assignment of reports to the respective patients in the medical practice or clinic. During that procedure, the specimen may pass through the hands of more than twenty individuals in several workplaces, and none of them can be expected to be focused fully on his or her duty in every minute of every day [25] .
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One of the most effective means of reducing error in that complex procedure is standardizing processes wherever possible. The reason is that work is usually, and most effectively, performed on the basis of automatic, reflex-type behavior, the so-called "schematic control mode," rather than controlled conscious thought or processing, the "attentional control mode." Conscious thought is activated by a seemingly new or novel problem for which no preconceived schema for solution exists; it is slow and effortful. With increasing experience, mental schemas to handle recurrent problems are developed and trained by repetitive behavior in myriad corresponding situations. The "schematic control mode" allows experts to function fast and effortless. Once activated by conscious intention, subsequent actions are relatively automatic and usually reliable. However, if misconceived signals initiate a wrong action, the latter is likely to be carried through without being noticed. Examples are slips in which the wrong automatic action is used, such as putting away a slide that has not been studied, and lapses, the omission of an automatic action, such as skipping a slide in a tray or leaving out a key word in a report (e.g., "malignancy" instead of "no malignancy"). Any breach in routine standardized processes carries an enhanced risk of inducing slips and lapses. The latter are far more common than mistakes resulting from failures in conscious judgment and are less likely to be noted because they involve situations perceived as being non-problematic.
In order to prevent signals that induce misguided automatic actions, standardization is crucial. In the operating room, sample bottles containing only formalin should always be taken from the same place, and sample bottles with specimens should be deposited at another place and always in the same way. In the laboratory, sample bottles, tissue cassettes, paraffin blocks, and slides should always be arranged in the same manner, the intend being to make it difficult for individuals to err by allowing them to function reliably without conscious thought [26, 27] .
Computer-assisted work
Another means to prevent mistakes is automation of processes. For example, when labeling tissue blocks by hand, the same number may accidentally be accorded twice, digits may be interchanged, or they may not be written clearly and may be misread later on. Automatic labeling of blocks or specimen slides in a printer prevents such mistakes ( Figure 1 ) [4, 20] .
The incorrect transcription of data, such as name or date of birth of the patient or number of the biopsy specimen, can be prevented by bar codes. Once those data have been converted into a bar code, they do not need to be typed anew in subsequent work steps. In laboratory medicine, a dramatic decrease of specimen labeling mistakes has been reported from numer- ous medical centers following adoption of a continuous bar code system [28] . In laboratories receiving specimens from external institutes, a continuous bar code system is difficult to implement, but bar codes should at least be used within the laboratory. In one study from a pathology department, adoption of a bar code system led to a reduction of specimen labeling mistakes by 98% [4] . Ideally, bar codes should be used not only for labeling sample bottles and request forms but also for tissue cassettes, paraffin blocks, and slides, but the costs for establishing such a system may be prohibitive.
Moreover, it must be kept in mind that one-dimensional bar codes are not perfectly safe but may occasionally be misread. and "Gran-ang," the diagnosis of richly vascularized granulation tissue may be given for a case of granuloma annulare.
Recognition and elimination of such sources of confusion enhances the reliability of histopathologic diagnosis.
Redundancy also implies that at least two unrelated data should be provided side by side at each work step, such as the name of the patient and the date of birth or a unique patient identifier on all sample bottles and request slips. Labeling bottles with the name only has been found to increase the rate of mistakes in specimen identification [29] . If the names of two patients are similar, as in married couples, siblings, or parents and their children, a special warning sign may be helpful, e.g., color marking of the forename. In the laboratory, the pathology number should be accompanied by the patient's name. This is not always possible. For example, tissue blocks are too small to carry several data. In the absence of control by the patient's name, diligence should be heightened, e.g., The computer system should not allow two files of patients to be opened at the same time so that the accidental entry of data into the wrong file becomes impossible. A particularly helpful, but also risky, option provided by computers is the "copy and paste" function that allows an elaborate text to be copied into a different file. Texts that have been marked are kept in the computer's clipboard, and if the "paste" function is activated accidentally later on, the copied report may be issued for an unrelated biopsy specimen unless the clipboard has been cleared previously.
Order
An essential requirement for every step in the biopsy pathway is order. The aura of a "creative chaos" cherished by some pathologists and created deliberately by piling up trays with innumerable slides in all corners of their room, intermingled with memos, medical journals, and used coffee cups, is dangerous. Workplaces must be tidy, no matter whether in the operating room or at the computer, laboratory bench, or microscope. One of the chief rules is to keep only one procedure in sight. When typing down the data of patients or dictating or typewriting histopathology reports, requests slips may lie on top of one another so that only the uppermost one is visible, but never side-by-side (Figure 2A, B) .
In the operating room, the file of the current patient should be separated from all other files. Sample bottles should should be checked that all bottles contain a specimen, that they are labeled correctly with all requisite data, and that the covers are screwed down tightly. If covers are loose, and formalin leaks out, it may render labels illegible. This is the case especially if bottles are labeled with a permanent marker pen.
The ink of marker pens is dissolved by formalin ( Figure 4 ).
Use of adhesive labels with written or printed data is preferable. Depending on the batch, however, not all adhesive labels adhere firmly. Therefore, firm adherence of them should be checked ( Figure 5 ). In addition, sample bottles and request forms should be checked for completeness and concordance in regard to names, numbers, and biopsy sites. Bottles should then be placed in a closed plastic bag before being sent off in one envelope together with the corresponding request forms.
According to a current survey among American dermatologists concerning medical error in dermatology practice, nine of ten assessment errors involved the biopsy pathway, and the most common of those errors accounting for 18% of them was incorrect information on the sample bottle or the request form [25] .
Those data are in accordance with the experience in general pathology. Most errors in the assignment of specimens, according to the literature nearly three quarters, occur in the pre-analytic phase, i.e., in the practice of the submitting clinician or in the laboratory during unpacking of envelopes, correlation of sample bottles and request forms, and numbering of specimens [4, 29, 30] . Especially in those phases, strict order is essential. The workspace for unpacking envelopes must be big enough to allow sample bottles and request forms from one envelope to be arranged in a clear fashion. Sample bottles should be placed on top of the corresponding request forms.
Several specimens from the same patient should be compiled before labeling them with ascending pathology numbers corresponding to the sequence of biopsies indicated on bottles and request forms ( Figure 6 ). Only one envelope should be unpacked at a time; all specimens of that envelope should be with some other adverse influence, such as an interruption through a telephone call, the risk is considerable that the error will not be discovered when resuming work.
Cleanliness
In addition to order, cleanliness is an essential requirement in all steps of the biopsy pathway. This is especially true for the water bath must be kept clean, and the water must be changed at regular intervals ( Figure 13A, B) . Contamination of one specimen with fragments of another is one of the most common causes of misdiagnosis secondary to mix-up of tissue [16] . In one study, 0.6% to 2.9% of all slides were found to be contaminated by extraneous tissue. In most of those cases, contaminants were confined to single sections and, therefore, resulted from contamination after embedding of specimens in paraffin blocks [31] . The accessioning of biopsy specimens in the laboratory, including unpacking of envelopes and sorting and numbering sample bottles and request forms, carries the greatest risk of specimen mix-up. In a study performed at more than 400 institutes of surgical pathology, accessioning accounted for nearly half of all deficiencies in specimen identification [29] . Therefore, it should be carried out by two persons simultaneously. The same is true for the end control of slides, before slides with sections of tissue and the corresponding request forms leave the laboratory and are forwarded for microscopy. The control of the correct, identical sequence of pathology numbers on slides, paraffin blocks, and request forms, and of the concordance of the shape of specimens in paraffin blocks and on slides, by at least two persons is essential ( Figure 14 ). According to one study, the error rate The secretaries typewriting reports should notice inconsistencies in them, such as discrepancies between the dictated report and data on the request form (e.g., a computer code for an inflammatory dermatosis in a specimen suspected to be a neoplasm clinically; attestation of complete removal in a biopsy declared as incomplete) or contradicting statements (e.g., "no evidence of malignancy" in a basal-cell carcinoma;
"complete removal" together with a note that the neoplasm extends to one lateral margin). Ideally, computerized systems should include a barrier for unusual or incompatible combinations of codes [26] . When errors are noted in the chain of downstream control, they should be corrected immediately. Any error that is allowed to persist may be missed later on and may result in an incorrect report. Severe mistakes rarely result from a single error but typically from a combination of "latent" and "active" errors [26] . Even if the precipitating error is relatively trivial, e.g., correct designation but inverse listing of two biopsy specimens on a request slip (specimen 2 being listed above specimen 1), it should be corrected by filling out a new request form or by at least highlighting the inverse sequence by an eye-catching warning sign. Any "latent" error corrected early on reduces the risk of more serious errors following it.
Clues for control
The chain of downstream control is the most expedient mechanism to detect and correct errors in the biopsy pathway.
However, it can only work if appropriate clues are provided in preceding work steps that allow inconsistencies to be detected later on. For example, the size and shape of biopsy specimens should be documented in the laboratory before dissecting specimens in order to fit them into tissue cassettes. If this is done, a subsequent mix-up can be detected by comparing those data with the histopathologic section on the slide. The precise way in which specimens are dissected should also be documented in order to enable technicians to note a missing or superfluous piece of tissue when preparing paraffin blocks.
Moreover, by describing precisely the size and shape of the obtained biopsy specimen to the submitting clinician, a mixup of specimens in the clinic or medical practice can often be verified. Unfortunately, the latter option is being curtailed progressively by the ever-increasing number of very small and shallow shave biopsies. The specimens obtained by such biopsies usually cannot be told from one another. Moreover, very small and narrow biopsy specimens preclude recognition to the quality of service. Unnecessary interruptions concerning problems that could also be discussed at another time, however, should be avoided. Any interruption is a potential source of error [27] . Because short-term memory is a particularly fallible human faculty, requirement for it should be minimized [26] . In case of an interruption, work should not be stopped in the middle of a procedure, such as dictation or typewriting of a report, but should first be finished before responding to the new request, and doubled care is necessary when resuming work, e.g., by renewed control of the name of the patient and of the pathology number on the slide and request form.
In addition to interruptions, there are other pitfalls in the biopsy pathway that should be known and respected, including similar or identical names of patients and deviation from the regular ascending sequence of pathology numbers. Any empty space on a tray bears the risk that a slide is put back at a wrong position and the subsequent slide being grabbed does not correspond to the next request form. Yet another pitfall is paperclips that attach some additional information to a request form. If such paperclips catch another request form, more than one form may be put aside after dictation, and the next report may be issued erroneously for the wrong patient. Habitual palpation of the paper of the request form to make sure that only one request form is taken from the pile and put aside after dictation of a report; heightened attention in the case of paperclips that may catch another, unrelated request form workload [4] . The opposite extreme, a very low workload, is also error-prone because boredom leads to poor performance.
Performance is best at moderate levels of arousal [26] .
Documentation of errors
If errors are uncovered, they should not only be corrected but also documented. Documentation of errors heightens the awareness of problems and offers the chance to expose and resolve recurrent sources of error. In institutes with a formal plan for handling errors, errors are less common [29] . Errors should be classified according to type and probable place of occurrence (e.g., labeling sample bottles in the medical practice, unpacking and numbering specimens in the laboratory, examining slides at the microscope). Systematic documentation of errors in the computer facilitates analysis of them [4] . 
